Spica Therapeutics
PrivateLast Round
Grant
Aug 27, 2025
Total Funding Raised
$12.8M
Momentum Score
25 /100
Company Overview
Spica Therapeutics is a drug discovery company that operates a proprietary platform intended to target disease-relevant macrophage subsets for therapeutic purposes.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Spica Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Spica Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 27, 2025 | ||||
| Seed | Jun 4, 2025 |
Key People
Founding team and executive leadership
Spica Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Qbic Fund | Seed |
| VLAIO | Grant |
| Flanders Future Tech Fund | Seed |
| Bioqube Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 27, 2025
$1.2M grant received
- Jun 4, 2025
$12M raised in Seed round.
Spica Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Spica Therapeutics's valuation, stock price, and market status.
